Our Mission & Vision
JHTV aims to maximize the impact of Johns Hopkins University’s research excellence by facilitating the translation and commercialization of discoveries into accessible technologies, products and services that benefit society.
Proven Track Record
Since 2014, JHTV has been advancing innovation ecosystems and developing tomorrow's solutions for today's biggest challenges.
43,000 SQ Ft
of incubator space
available for licensing
170+ Commercial Startups
in venture funding raised by portfolio companies
37 Active research collaborations
2021 annual report
Inspired by the efficacy of gastric bypass surgery in correcting the metabolic disorder associated with type 2 diabetes, Glyscend Therapeutics is developing a pill to mimic the effects of the surgery to improve a patient’s blood glucose and reduce body weight. The technology is designed to work only in specific portions of the gastrointestinal tract and could potentially help the approximately 500 million people worldwide with type 2 diabetes.